Luminex Corporation  

Austin,  TX 
United States
http://www.luminexcorp.com
  • Booth: 1867

Booth Profile

Luminex Corporation is committed to creating innovative, breakthrough solutions to help our customers improve health and advance science worldwide. We serve the needs of our customers in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, and personalized medicine. Our goal is to transform global healthcare and life science research through the development, manufacturing, and marketing of proprietary instruments and assays that deliver cost-effective, rapid results to clinicians and researchers. For further information, please visit http://www.luminexcorp.com/.


 Products

  • VERIGENE® II
    VERIGENE® II is an exciting new product that combines the innovative, multiplexing, molecular diagnostic capabilities of Luminex’s current VERIGENE® SP and Reader into one innovative System. This sample to result platform reduces assay hands-on time and improves flexibility in target selection, pricing, and overall lab management....
         

  • VERIGENE® II is an exciting new product that combines the innovative, multiplexing, molecular diagnostic capabilities of Luminex’s current VERIGENE® SP and Reader into one innovative system. This sample to result platform reduces assay hands-on time by automating nucleic acid extraction, purification, amplification, and hybridization within a single consumable. VERIGENE® II improves flexibility in overall lab management by allowing a system configuration based on current lab sample volumes, bidirectional LIS for easy data analysis, as well as customized Flex assay panels that report only the selected targets of interest.  Discover the next generation VERIGENE® II for simple, fast, flexible detection of infectious diseases and pathogens

    This system/assays are under development and not currently FDA cleared/CE marked

    Some features may not be availalable at launch


 Additional Info

Included in the Export Interest Directory?
Yes
Business Needs:
Investor
Products to be exported:
VERIGENE® II is an exciting new product that combines the innovative, multiplexing, molecular diagnostic capabilities of Luminex’s current VERIGENE® SP and Reader into one innovative System. This sample to result platform reduces assay hands-on time and improves flexibility in target selection, pricing, and overall lab management.